Training for Men Undergoing Androgen Deprivation Therapy.

The goal of this clinical trial is to evaluate the effects of a newly developed training concept on men with prostate cancer undergoing androgen deprivation therapy (ADT). The main questions it aims to answer are: * How feasible and safe is the new training concept? * How efficient is the training concept to counteract side effects caused by ADT? Researchers will compare the new training concept with usual care to evaluate how efficient the training concept is to counteract the ADT-related side effects. Participants in the intervention group will perform the new training concept twice weekly for 12 weeks. Participants in the control group will only receive usual care. All participants will visit the laboratory at baseline and after 6 and 12 weeks to measure the primary and secondary outcomes.

NCT Number	NCT06449664
Lead Sponsor	The Swedish School of Sport and Health Sciences Collaborators: Norwegian School of Sport Sciences, Karolinska Institutet, Prostate Cancer Foundation, Sahlgrenska University Hospital
Conditions	Prostate Cancer
Enrollment	60 participants
Start Date	2024-05-01
Primary Completion	2026-12 (estimated)
Study Completion	2028-12-20 (estimated)
Updated on ClinicalTrials.gov	2024-06-10